NanoBio received exclusive, worldwide rights from NIH to an antigen against respiratory syncytial virus (RSV)

National Institutes of Health

U.S. / Government

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

NanoBio Corp.

U.S. / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced